On the list of popular cancers, campaign strategically speaking, bladder cancer is performing bad. That is in stark contrast to other statistics.
It is the 7th most common cancer in the UK and the 5th most common in the western world. Despite being a common cancer and the only top 10 cancer where the prognosis is getting worse, it only gets 0.6% of cancer research spend. This is for a cancer that is the most expensive there is for the NHS (UK) to treat. That’s why three British charities, Action on Bladder Cancer, Fight Bladder Cancer and The Urology Foundation have joined forces to launch a crucial campaign. According to the charities the situation is so distressing that they Shout Out About Bladder Cancer, which is the name of the collaboration.
Both patients and the medical profession are very concerned that this cancer is going to be sidelined even more than it is now. This is why these charities, the top medical people who deal with this cancer and patients all across the UK want to highlight this marginalised cancer and change things.
If caught early there is an 80% chance of survival. If caught late survival reduces to 25% or less. Late diagnosis shouldn’t happen but it does for a number of reasons. That is the focus of the campaign. It is shout out about the worldwide shortage of an essential life saving drug. It is also a demand for additional guidelines.
Jim Catto, Professor in Urological Surgery, University of Sheffield:
For years bladder cancer has been an under- funded, under-discussed and under-treated disease. In contrast to most cancers, survival rates from bladder cancer have not improved and are falling. National trends reveal today’s disease is more lethal and more evenly spread across the population than yesterday’s cancers. A concerted effort to improve the landscape is needed for patients with this common, expensive and lethal disease.
The campaign is told through real stories by real people.
More information, downloads and campaign material is on the Shout Out About Bladder Cancer campaign website. See also the infographic below.